ROBERT BRIAN JENKINS, M.D.
Medical Practice at 1 St, Rochester, MN
License number
Minnesota 28728
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
200 1St St SW, Rochester, MN 55905
Phone
(507) 284-2511
Professional information
Dr. Robert B Jenkins, Rochester MN - MD (Doctor of Medicine)
Specialties:
Clinical Pathology, Clinical Cytogenetics, Clinical Molecular Genetics
Address:
Mayo Clinic
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
200 1St St SW, Rochester 55905
(507) 284-2511 (Phone)
Certifications:
Clinical Cytogenetics, 1990, Clinical Molecular Genetics, 2006, Clinical Pathology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
200 1St St SW, Rochester 55905
Mayo Clinic Methodist Hospital
201 West Center St, Rochester 55902
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1983
Mayo Grad School Med/Mayo Fndn
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1983
Mayo Grad School Med/Mayo Fndn
Methods And Probe Sets For Determining Prostate Cancer Prognosis
US Patent:
6613510, Sep 2, 2003
Filed:
Apr 28, 1999
Appl. No.:
09/301062
Inventors:
Robert B. Jenkins - Rochester MN
Kazunari Sato - Rochester MN
Junqi Qian - Rochester MN
Kazunari Sato - Rochester MN
Junqi Qian - Rochester MN
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 168
US Classification:
435 6, 536 231, 536 243
Abstract:
Methods and kits for determining prostate cancer prognosis in a subject are described. The hybridization pattern of a set of chromosomal probes is correlated with prostate cancer prognosis in the subject.
Method And Probe Set For Detecting Cancer
US Patent:
6376188, Apr 23, 2002
Filed:
Jul 21, 2000
Appl. No.:
09/621173
Inventors:
Kevin C. Halling - Rochester MN
Robert B. Jenkins - Rochester MN
Walter King - Wheaton IL
Irina A. Sokolova - Lombard IL
Steven A. Seelig - Naperville IL
Robert B. Jenkins - Rochester MN
Walter King - Wheaton IL
Irina A. Sokolova - Lombard IL
Steven A. Seelig - Naperville IL
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
Vysis, Inc. - Downers Grove IL
Vysis, Inc. - Downers Grove IL
International Classification:
C12Q 168
US Classification:
435 6, 435325, 4352871, 4352883, 536 231, 536 243, 536 2431
Abstract:
Methods for detecting cancer that include hybridizing a set of chromosomal probes to a biological sample obtained from a patient, and identifying if aneusomic cells are present in a selected subset of cells obtained from the biological sample are described. A set of chromosomal probes and kits for detecting cancer that include sets of chromosomal probes, are also described.
Cancer Diagnostics Using Biomarkers
US Patent:
2014006, Mar 6, 2014
Filed:
Aug 16, 2013
Appl. No.:
13/968838
Inventors:
- Vancouver, CA
Elai Davicioni - La Jolla CA, US
Nicholas George Erho - Vancouver, CA
Mercedeh Ghadessi - New Westminister, CA
Robert B. Jenkins - Rochester MN, US
Ismael A. Vergara Correa - West Vancouver, CA
Elai Davicioni - La Jolla CA, US
Nicholas George Erho - Vancouver, CA
Mercedeh Ghadessi - New Westminister, CA
Robert B. Jenkins - Rochester MN, US
Ismael A. Vergara Correa - West Vancouver, CA
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
GENOMEDX BIOSCIENCES INC. - Vancouver
GENOMEDX BIOSCIENCES INC. - Vancouver
International Classification:
C12Q 1/68
US Classification:
506 9, 506 16, 435 612
Abstract:
Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
Method And Probe Set For Detecting Cancer
US Patent:
2012027, Nov 1, 2012
Filed:
Jul 2, 2012
Appl. No.:
13/540260
Inventors:
Kevin C. Halling - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Walter King - Wheaton IL, US
Irina A. Sokolova - Villa Park IL, US
Steven A. Seelig - Elmhurst IL, US
Robert B. Jenkins - Rochester MN, US
Walter King - Wheaton IL, US
Irina A. Sokolova - Villa Park IL, US
Steven A. Seelig - Elmhurst IL, US
International Classification:
C12Q 1/68
US Classification:
435 611
Abstract:
Methods for detecting cancer that include hybridizing a set of chromosomal probes to a biological sample obtained from a patient, and identifying if aneusomic cells are present in a selected subset of cells obtained from the biological sample are described. A set of chromosomal probes and kits for detecting cancer that include sets of chromosomal probes, are also described.
Biomarker Panels For Predicting Prostate Cancer Outcomes
US Patent:
2009029, Dec 3, 2009
Filed:
May 29, 2009
Appl. No.:
12/474879
Inventors:
George G. Klee - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Thomas M. Kollmeyer - Rochester MN, US
Karla V. Ballman - Northfield MN, US
Eric J. Bergstralh - Mazeppa MN, US
Bruce W. Morlan - Northfield MN, US
S. Keith Anderson - Rochester MN, US
Tohru Nakagawa - Tokyo, JP
Robert B. Jenkins - Rochester MN, US
Thomas M. Kollmeyer - Rochester MN, US
Karla V. Ballman - Northfield MN, US
Eric J. Bergstralh - Mazeppa MN, US
Bruce W. Morlan - Northfield MN, US
S. Keith Anderson - Rochester MN, US
Tohru Nakagawa - Tokyo, JP
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.
Method And Probe Set For Detecting Cancer
US Patent:
6174681, Jan 16, 2001
Filed:
Mar 5, 1999
Appl. No.:
9/264149
Inventors:
Kevin C. Halling - Rochester MN
Robert B. Jenkins - Rochester MN
Walter King - Wheaton IL
Irina A. Sokolova - Lombard IL
Steven A. Seelig - Naperville IL
Robert B. Jenkins - Rochester MN
Walter King - Wheaton IL
Irina A. Sokolova - Lombard IL
Steven A. Seelig - Naperville IL
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 168, C07H 2104
US Classification:
435 6
Abstract:
Methods for detecting cancer that include hybridizing a set of chromosomal probes to a biological sample obtained from a patient, and identifying if aneusomic cells are present in a selected subset of cells obtained from the biological sample are described. A set of chromosomal probes and kits for detecting cancer that include sets of chromosomal probes, are also described.
Method And Probe Set For Detecting Cancer
US Patent:
7232655, Jun 19, 2007
Filed:
Apr 12, 2002
Appl. No.:
10/121483
Inventors:
Kevin C. Halling - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Walter King - Wheaton IL, US
Irina A. Sokolova - Lombard IL, US
Steven A. Seelig - Naperville IL, US
Robert B. Jenkins - Rochester MN, US
Walter King - Wheaton IL, US
Irina A. Sokolova - Lombard IL, US
Steven A. Seelig - Naperville IL, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
Vysis, Inc. - Downers Grove IL
Vysis, Inc. - Downers Grove IL
International Classification:
C07H 21/04, C12Q 1/68
US Classification:
435 6, 536 2432, 536 243, 536 231
Abstract:
Methods for detecting cancer that include hybridizing a set of chromosomal probes to a biological sample obtained from a patient, and identifying if aneusomic cells are present in a selected subset of cells obtained from the biological sample are described. A set of chromosomal probes and kits for detecting cancer that include sets of chromosomal probes, are also described.
Peptide-Mediated Non-Covalent Delivery Of Active Agents Across The Blood-Brain Barrier
US Patent:
2012010, May 3, 2012
Filed:
Jul 14, 2010
Appl. No.:
13/383710
Inventors:
Geoffry L. Curran - Rochester MN, US
Gobinda Sarkar - Rochester MN, US
Joseph F. Poduslo - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Val J. Lowe - Rochester MN, US
Eric W. Mahlum - Rochester MN, US
Gobinda Sarkar - Rochester MN, US
Joseph F. Poduslo - Rochester MN, US
Robert B. Jenkins - Rochester MN, US
Val J. Lowe - Rochester MN, US
Eric W. Mahlum - Rochester MN, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 49/00, C07K 9/00, C07K 14/00, C07K 7/08, C07K 7/06, C07K 5/10, C07K 16/00, A61P 35/00, A61K 38/08, A61K 38/10, A61P 25/00, A61P 25/08, A61P 25/16, A61P 25/28, A61P 31/18, A61K 38/07
US Classification:
424 91, 514 12, 530322, 530324, 530325, 530326, 530327, 530328, 530329, 530330, 530359, 5303913
Abstract:
The peptides described herein can function as carrier peptides. These peptides can associate with (e.g., non-covalently bind) biologically active molecules or imaging agents to transport the biologically active molecules or imaging across the blood-brain barrier. In some cases, such transport may increase the effectiveness of the biological molecules or imaging agents.
Detecting T(1;19)
US Patent:
7794940, Sep 14, 2010
Filed:
May 4, 2007
Appl. No.:
11/744647
Inventors:
Robert B. Jenkins - Rochester MN, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
This document provides methods and materials related to detecting t(1;19) as well as methods and materials for identifying or assessing cancer within a mammal (e. g. , a human). For example, methods for assessing the aggressiveness of a low-grade glioma in a human are provided.